Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Merck
Baxter
Mallinckrodt
Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INSULATARD NPH HUMAN

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Insulatard Nph Human

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00346996 Insulin Analogues and Severe Hypoglycaemia Completed Novo Nordisk A/S Phase 4 2007-05-01 Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00346996 Insulin Analogues and Severe Hypoglycaemia Completed Lise Tarnow Phase 4 2007-05-01 Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00566124 Basal Insulins - Pharmacodynamics Completed Novo Nordisk A/S Phase 4 2005-01-01 To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124 Basal Insulins - Pharmacodynamics Completed The Danish Diabetes Association Phase 4 2005-01-01 To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124 Basal Insulins - Pharmacodynamics Completed The Institute of Experimental Clinical Research, University of Aarhus Phase 4 2005-01-01 To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124 Basal Insulins - Pharmacodynamics Completed University of Aarhus Phase 4 2005-01-01 To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00657930 Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir) Completed Novo Nordisk A/S N/A 2008-03-01 This study is conducted in Europe. The aim of this observational study is to gain practical experience with once-daily Levemir administration in type 2 diabetes patients who were previously treated with Insulatard®, Humulin® N (NPH insulins) as basal insulin as part of their ICT under normal clinical practice conditions in Hungary.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Insulatard Nph Human

Condition Name

Condition Name for Insulatard Nph Human
Intervention Trials
Diabetes 7
Diabetes Mellitus, Type 2 4
Type 1 Diabetes 2
Healthy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Insulatard Nph Human
Intervention Trials
Diabetes Mellitus 8
Diabetes Mellitus, Type 2 6
Diabetes Mellitus, Type 1 4
Hyperglycemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Insulatard Nph Human

Trials by Country

Trials by Country for Insulatard Nph Human
Location Trials
Denmark 3
Germany 2
Romania 1
Austria 1
Hungary 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Insulatard Nph Human

Clinical Trial Phase

Clinical Trial Phase for Insulatard Nph Human
Clinical Trial Phase Trials
Phase 4 5
Phase 2 1
Phase 1 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Insulatard Nph Human
Clinical Trial Phase Trials
Completed 10
Unknown status 2
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Insulatard Nph Human

Sponsor Name

Sponsor Name for Insulatard Nph Human
Sponsor Trials
Novo Nordisk A/S 8
Rigshospitalet, Denmark 1
University of Aarhus 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Insulatard Nph Human
Sponsor Trials
Other 10
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Moodys
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.